Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Novartis Novartis Vaccines |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00310700 |
Kinetics of B cell response in infants Menjugate vaccination
Condition | Intervention | Phase |
---|---|---|
Prevention of Meningococcal Infection |
Biological: Meningococcal C conjugate vaccine |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | A Phase IV, Single Centre, Open-Label Study to Investigate the Kinetics of the B Cell Response to the First and the Third Immunization With Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Infants at 2, 3 and 4 Months of Age |
Estimated Enrollment: | 75 |
Study Start Date: | May 2005 |
Ages Eligible for Study: | 8 Weeks to 11 Weeks |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom, OXON | |
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital | |
Oxford, OXON, United Kingdom, OX3 7LJ |
Principal Investigator: | Novartis Vaccines - Information Services | Novartis Vaccines & Diagnostics |
Study ID Numbers: | M14P5, Impact N° 1457 |
Study First Received: | April 3, 2006 |
Last Updated: | March 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00310700 History of Changes |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Prevention of Meningococcal Meningitis vaccines, conjugate immunology infant antibody persistence |
Bacterial Infections Antibodies Meningococcal Infections Meningitis, Meningococcal Meningococcal Infection |
Healthy Immunoglobulins Gram-Negative Bacterial Infections Neisseriaceae Infections Meningitis |
Bacterial Infections Meningococcal Infections Infection Gram-Negative Bacterial Infections Neisseriaceae Infections |